Personalis, Inc. (PSNL) stock
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30335% above fair value
$14.72−0.26 (-1.74%)
Close on Nov 19, 2026Market cap $1.57BP/E –Yield –
Personalis gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Personalis's gross profit for the twelve months ending Jun 30, 2026 was $8.84M, down 65.0% year over year. For fiscal 2025 it was $15.78M, down 41.2% from the year before. The highest annual figure on record is $31.66M in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.78M | -41.2% |
| FY2024 | Dec 31, 2024 | $26.83M | +47.3% |
| FY2023 | Dec 31, 2023 | $18.21M | +36.4% |
| FY2022 | Dec 31, 2022 | $13.35M | -57.8% |
| FY2021 | Dec 31, 2021 | $31.66M | +57.4% |
| FY2020 | Dec 31, 2020 | $20.11M | -8.9% |
| FY2019 | Dec 31, 2019 | $22.08M | +87.0% |
| FY2018 | Dec 31, 2018 | $11.81M | – |
| FY2017 | Dec 31, 2017 | -$2.34M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.74M | -0.3% |
| Q1 FY2026 | Mar 31, 2026 | $281.00K | -96.1% |
| Q4 FY2025 | Dec 31, 2025 | $1.90M | -58.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.91M | -78.1% |
| Q2 FY2025 | Jun 30, 2025 | $4.76M | -40.8% |
| Q1 FY2025 | Mar 31, 2025 | $7.21M | +31.2% |
| Q4 FY2024 | Dec 31, 2024 | $4.55M | -12.6% |
| Q3 FY2024 | Sep 30, 2024 | $8.75M | +151.2% |
| Q2 FY2024 | Jun 30, 2024 | $8.04M | +67.7% |
| Q1 FY2024 | Mar 31, 2024 | $5.49M | +16.1% |
| Q4 FY2023 | Dec 31, 2023 | $5.21M | +125.1% |
| Q3 FY2023 | Sep 30, 2023 | $3.48M | +40.4% |
| Q2 FY2023 | Jun 30, 2023 | $4.79M | +11.9% |
| Q1 FY2023 | Mar 31, 2023 | $4.73M | +10.6% |
| Q4 FY2022 | Dec 31, 2022 | $2.31M | -71.1% |
| Q3 FY2022 | Sep 30, 2022 | $2.48M | -69.3% |
| Q2 FY2022 | Jun 30, 2022 | $4.28M | -47.6% |
| Q1 FY2022 | Mar 31, 2022 | $4.28M | -42.4% |
| Q4 FY2021 | Dec 31, 2021 | $8.00M | +31.7% |
| Q3 FY2021 | Sep 30, 2021 | $8.07M | +51.2% |
| Q2 FY2021 | Jun 30, 2021 | $8.17M | +74.8% |
| Q1 FY2021 | Mar 31, 2021 | $7.43M | +83.9% |
| Q4 FY2020 | Dec 31, 2020 | $6.07M | -7.5% |
| Q3 FY2020 | Sep 30, 2020 | $5.33M | -5.3% |
| Q2 FY2020 | Jun 30, 2020 | $4.67M | -20.8% |
| Q1 FY2020 | Mar 31, 2020 | $4.04M | +1.4% |
| Q4 FY2019 | Dec 31, 2019 | $6.57M | +35.9% |
| Q3 FY2019 | Sep 30, 2019 | $5.63M | +25.6% |
| Q2 FY2019 | Jun 30, 2019 | $5.90M | +146.3% |
| Q1 FY2019 | Mar 31, 2019 | $3.98M | +3924.2% |
| Q4 FY2018 | Dec 31, 2018 | $4.83M | – |
| Q3 FY2018 | Sep 30, 2018 | $4.48M | – |
| Q2 FY2018 | Jun 30, 2018 | $2.40M | – |
| Q1 FY2018 | Mar 31, 2018 | $99.00K | – |
See a number that looks wrong?